Vor Ort
Merkzettel Warenkorb
Produktbild: Molecular Pharmacology

Molecular Pharmacology From DNA to Drug Discovery

189,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

22.01.2013

Verlag

John Wiley & Sons Inc

Seitenzahl

424

Maße (L/B/H)

25,1/18,8/2,3 cm

Gewicht

1043 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-0-470-68444-3

Beschreibung

Rezension

"An informative, comprehensive text, it is highly recommended to postgraduates and researchers in both pharmacology and molecular biology." (Science Progress, 1 March 2014)
 
"Overall, it could be the basis of an excellent course for junior pharmacologists in basic science research who need a greater focus on the mechanisms of drug action rather than an encyclopedic survey of clinical drug use." (Doody's, 26 July 2013)

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

22.01.2013

Verlag

John Wiley & Sons Inc

Seitenzahl

424

Maße (L/B/H)

25,1/18,8/2,3 cm

Gewicht

1043 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-0-470-68444-3

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: GPSR Kontakt

Ein neues Kapitel für Ihre Bücher

Ein neues Kapitel für Ihre Bücher

Schenken Sie Ihren alten Schätzen ein zweites Leben: Einfach Barcode scannen, Versandetikett ausdrucken, Bücher verschicken und Thalia Geschenkkarte erhalten.

Jetzt verkaufen
Jetzt verkaufen

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
Die Leseprobe wird geladen.
  • Produktbild: Molecular Pharmacology
  • Preface ix
     
    Abbreviations x
     
    1 Introduction to Drug Targets and Molecular Pharmacology 1
     
    1.1 Introduction to molecular pharmacology 1
     
    1.2 Scope of this textbook 2
     
    1.3 The nature of drug targets 3
     
    1.4 Future drug targets 7
     
    1.5 Molecular pharmacology and drug discovery 11
     
    References 12
     
    2 Molecular Cloning of Drug Targets 13
     
    2.1 Introduction to molecular cloning - from DNA to drug discovery 13
     
    2.2 'Traditional' pharmacology 14
     
    2.3 The relevance of recombinant DNA technology to pharmacology/drug discovery 14
     
    2.4 The 'cloning' of drug targets 15
     
    2.5 What information can DNA cloning provide? 20
     
    2.6 Comparing the pharmacologic profile of the 'cloned' and the 'native' drug target 23
     
    2.7 Reverse pharmacology illustrated on orphan GPCRs 24
     
    2.8 Summary 27
     
    References 27
     
    3 G Protein-coupled Receptors 31
     
    3.1 Introduction to G protein-coupled receptors 31
     
    3.2 Heterotrimeric G-proteins 36
     
    3.3 Signal transduction pathways 40
     
    3.4 Desensitisation and down-regulation of GPCR signalling 44
     
    3.5 Constitutive GPCR activity 45
     
    3.6 Promiscuous G-protein coupling 47
     
    3.7 Agonist-directed signalling 48
     
    3.8 Allosteric modulators of GPCR function 49
     
    3.9 Pharmacological chaperones for GPCRs 50
     
    3.10 GPCR dimerisation 51
     
    3.11 GPCR splice variants 63
     
    3.12 Summary 67
     
    References 67
     
    Useful Web sites 70
     
    4 Ion Channels 71
     
    4.1 Introduction 71
     
    4.2 Voltage-gated ion channels 73
     
    4.3 Other types of voltage-gated ion channels 89
     
    4.4 Ligand-gated ion channels 109
     
    4.5 Summary 125
     
    References 125

    5 Transporter Proteins 129
     
    5.1 Introduction 129
     
    5.2 Classification 129
     
    5.3 Structural analysis of transporters 132
     
    5.4 Transporter families of pharmacological interest 133
     
    5.5 Transporters and cellular homeostasis 167
     
    5.6 Summary 169
     
    References 169
     
    6 Cystic Fibrosis: Alternative Approaches to the Treatment of a Genetic Disease 175
     
    6.1 Introduction 175
     
    6.2 Cystic fibrosis transmembrane conductance regulator 179
     
    6.3 Mutations in CFTR 183
     
    6.4 Why is cystic fibrosis so common? 184
     
    6.5 Animal models of Cystic fibrosis 186
     
    6.6 Pharmacotherapy 186
     
    6.7 Gene therapy 191
     
    6.8 Conclusion 195
     
    References 196
     
    7 Pharmacogenomics 201
     
    7.1 Types of genetic variation in the human genome 201
     
    7.2 Thiopurine S-methyltransferase and K+ channel polymorphisms 202
     
    7.3 Polymorphisms affecting drug metabolism 204
     
    7.4 Methods for detecting genetic polymorphisms 209
     
    7.5 Genetic variation in drug transporters 211
     
    7.6 Genetic variation in G protein coupled receptors 215
     
    7.7 Summary 225
     
    References 225
     
    Useful Web sites 226
     
    8 Transcription Factors and Gene Expression 227
     
    8.1 Control of gene expression 227
     
    8.2 Transcription factors 229
     
    8.3 CREB 233
     
    8.4 Nuclear receptors 238
     
    8.5 Peroxisome proliferator-activated receptors 240
     
    8.6 Growth factors 247
     
    8.7 Alternative splicing 247
     
    8.8 RNA editing 251
     
    8.9 The importance of non-coding RNAs in gene expression 257
     
    8.10 Summary 270
     
    References 271
     
    9 Cellular Calcium 277
     
    9.1 Introduction 277
     
    9.2 Measurement of calcium 278